Analysts' ratings for Globus Medical (NYSE:GMED) over the last quarter vary from bullish to bearish, as provided by 8 analysts. The following table provides a quick overview of their recent ratings, ...
AUDUBON, Pa. (AP) — AUDUBON, Pa. (AP) — Globus Medical Inc. (GMED) on Tuesday reported fourth-quarter earnings of $140.6 million. The Audubon, Pennsylvania-based company said it had net income of ...
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Masimo (MASI). But which of these two stocks is more attractive to value ...
Globus Medical Inc. (NYSE:GMED) is one of the best medical technology stocks to invest in. On January 30, Needham upgraded its rating on Globus Medical Inc. (NYSE:GMED) from Hold to Buy and set the ...
Hosted on MSN
Needham upgrades Globus Medical (GMED)
Fintel reports that on January 30, 2026, Needham upgraded their outlook for Globus Medical (NYSE:GMED) from Hold to Buy. Analyst Price Forecast Suggests 17.49% Upside As of January 14, 2026, the ...
Multi-year wins underscore sustained specialty-first innovation, workflow depth, and revenue-cycle performance at scale TAMPA, FLORIDA / ACCESS Newswire / January 15, 2026 / ModMed has again earned ...
Globus Medical is rated Hold, as growth is increasingly reliant on M&A and organic momentum remains muted. GMED's FY26 guidance implies 9% revenue growth, a sharp deceleration from FY25's 16.5%, with ...
A HIPAA-compliant, fully managed solution that enhances podiatry patient communication and drives measurable recall revenue through ModMed. DANBURY, CT, UNITED STATES ...
DANBURY, CT, UNITED STATES, January 6, 2026 /EINPresswire.com/ — Blue Orchid Marketing, the nation’s longest-running podiatry marketing agency, has introduced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results